(Photo Courtesy: www.span.co.in)
Ranbaxy Laboratories announced the following results for the quarter ended September 30, 2014:
The Unaudited Standalone results for the Quarter ended September 30, 2014
The Company has posted a net loss of Rs 3682.57 million for the quarter ended September 30, 2014, as compared to net loss of Rs 8422.32 million for the quarter ended September 30, 2013.
The total income has decreased from Rs 14701.86 million for the quarter ended September 30, 2013 to Rs 13389.31 million for the quarter ended September 30, 2014.
The Consolidated Results are as follows:
The Unaudited Consolidated results for the Quarter ended September 30, 2014
The Group has posted a net profit after tax, minority interest and share in profit of associates of Rs 4777.56 million for the quarter ended September 30, 2014 as compared to net loss of Rs 4541.69 million for the quarter ended September 30, 2013.
Total income has increased from Rs 28277.34 million for the quarter ended September 30, 2013 to Rs 32778.76 million for the quarter ended September 30, 2014.
